
Neurocrine Biosciences Sets Date for Q2 2026 Financial Results
San Diego-based Neurocrine Biosciences will disclose its second quarter 2026 financial performance on July 30, 2026. The biopharmaceutical firm plans to release its earnings report at 1:00 p.m. Pacific Time, followed by a live conference call and webcast for investors and analysts thirty minutes later.






















:max_bytes(150000):strip_icc()/GettyImages-487710168-8ce3389bc1474e21b93e6fdb4d8f68c3.jpg)


